Cas no 128252-98-2 (Chaetoviridin A)

Chaetoviridin A is a secondary metabolite produced by fungi of the genus Chaetomium. It exhibits notable bioactivity, including antimicrobial and cytotoxic properties, making it a compound of interest in pharmaceutical and agricultural research. Structurally, it belongs to the azaphilone class, characterized by a pyranoquinone core, which contributes to its stability and reactivity. Chaetoviridin A has demonstrated potential as an antifungal agent, particularly against plant pathogens, and shows promise in anticancer studies due to its ability to inhibit cell proliferation. Its unique mechanism of action and selective toxicity underscore its value as a lead compound for drug development and biocontrol applications.
Chaetoviridin A structure
Chaetoviridin A structure
Product Name:Chaetoviridin A
CAS No:128252-98-2
MF:C23H25ClO6
MW:432.894006490707
CID:220154
Update Time:2025-11-02

Chaetoviridin A Chemical and Physical Properties

Names and Identifiers

    • (6aS)-5-chloro-9-[(2S,3R)-3-hydroxy-2-methylbutanoyl]-6a-methyl-3-[(E,3S)-3-methylpent-1-enyl]furo[2,3-h]isochromene-6,8-dione
    • 6H-Furo[2,3-h]-2-benzopyran-6,8(6aH)-dione,5-chloro-9-[(2S,3R)-3-hydroxy-2-methyl-1-oxobutyl]-6a-methyl-3-[(1E,3S)-3-methyl-1
    • 6H-Furo[2,3-h]-2-benzopyran-6,8(6aH)-dione,5-chloro-9-[(2S,3R)-3-hydroxy-2-methyl-1-oxobutyl]-6a-methyl-3-[(1E,3S)-3-methyl-1-penten-1-yl]-,(6aS)-
    • CHAETOVIRIDIN A
    • (6aS)-5-Chloro-9-[(2S,3R)-3-hydroxy-2-methylbutanoyl]-6a-methyl-3-[(1E,3S)-3-methylpent-1-en-1-yl]-6H-furo[2,3-h]isochromene-6,8(6aH)-dione
    • 5'-Hydroxychaetoviridine F
    • (6aS)-5-Chloro-9-[(2S,3R)-3-hydroxy-2-methyl-1-oxobutyl]-6aα-methyl-3-[(1E,3S)-3-methyl-1-pentenyl]-6H-furo[2,3-h]-2-benzopyran-6,8(6aH)-dione
    • Chaetoviridin A
    • Inchi： 1S/C23H25ClO6/c1-6-11(2)7-8-14-9-15-16(10-29-14)18-17(20(26)12(3)13(4)25)22(28)30-23(18,5)21(27)19(15)24/h7-13,25H,6H2,1-5H3/b8-7+/t11-,12-,13+,23-/m0/s1
    • InChI Key： HWSQVPGTQUYLEQ-CCBHEJLASA-N
    • SMILES： ClC1=C2C=C(/C=C/[C@@H](C)CC)OC=C2C2=C(C(=O)O[C@]2(C)C1=O)C([C@@H](C)[C@@H](C)O)=O

Computed Properties

  • Exact Mass: 432.133966
  • Monoisotopic Mass: 432.133966
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 6
  • Heavy Atom Count: 30
  • Rotatable Bond Count: 6
  • Complexity: 980
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 4
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 1
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 89.9

Experimental Properties

  • Density: 1.31±0.1 g/cm3 (20 oC 760 Torr),
  • Melting Point: 157-158 oC
  • Boiling Point: 607.6°C at 760 mmHg
  • Flash Point: 321.3°C
  • Refractive Index: 1.587
  • Solubility: Insuluble (4.8E-3 g/L) (25 oC),

Chaetoviridin A Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
TRC
C291843-1mg
Chaetoviridin A
 128252-98-2
1mg
 $ 161.00 2023-04-18
TRC
C291843-2.5mg
Chaetoviridin A
 128252-98-2
2.5mg
 $ 322.00 2023-04-18
A2B Chem LLC
AE41283-5mg
(6aS)-5-Chloro-9-[(2S,3R)-3-hydroxy-2-methyl-1-oxobutyl]-6aα-methyl-3-[(1E,3S)-3-methyl-1-pentenyl]-6H-furo[2,3-h]-2-benzopyran-6,8(6aH)-dione
 128252-98-2 ≥95%
5mg
 $437.00 2024-04-20
SHENG KE LU SI SHENG WU JI SHU
sc-396533-1mg
Chaetoviridin A,
 128252-98-2
1mg
 ￥1158.00 2023-09-05
SHENG KE LU SI SHENG WU JI SHU
sc-396533A-5mg
Chaetoviridin A,
 128252-98-2
5mg
 ￥4212.00 2023-09-05
BioAustralis
BIA-C1907-0.50 mg
Chaetoviridin A
 128252-98-2 >95%byHPLC
0.50mg
 $166.00 2023-09-05
BioAustralis
BIA-C1907-2.50 mg
Chaetoviridin A
 128252-98-2 >95%byHPLC
2.50mg
 $581.00 2023-09-05
SHENG KE LU SI SHENG WU JI SHU
sc-396533-1 mg
Chaetoviridin A,
 128252-98-2
1mg
 ￥1,158.00 2023-07-10
SHENG KE LU SI SHENG WU JI SHU
sc-396533A-5 mg
Chaetoviridin A,
 128252-98-2
5mg
 ￥4,212.00 2023-07-10
BioAustralis
BIA-C1907-0.50mg
Chaetoviridin A
 128252-98-2 >95% by HPLC
0.50mg
 $180.00 2025-08-07

Chaetoviridin A Related Literature

Related Categories

Additional information on Chaetoviridin A

Chaetoviridin A (CAS No. 128252-98-2): A Promising Bioactive Compound with Diverse Applications

Chaetoviridin A (CAS No. 128252-98-2) is a naturally occurring secondary metabolite derived from fungal species, particularly those belonging to the genus Chaetomium. This compound has garnered significant attention in recent years due to its unique chemical structure and broad spectrum of biological activities. Researchers and industries alike are increasingly interested in Chaetoviridin A for its potential applications in pharmaceuticals, agriculture, and biotechnology.

The molecular structure of Chaetoviridin A features a complex polyketide backbone, which contributes to its diverse bioactivity. Studies have shown that this compound exhibits notable antimicrobial properties, making it a subject of interest in the fight against antibiotic-resistant pathogens. With the global rise of antimicrobial resistance (AMR) becoming a critical health concern, compounds like Chaetoviridin A offer promising alternatives for developing new therapeutic agents.

Beyond its antimicrobial effects, Chaetoviridin A has demonstrated potential as an anti-cancer agent. Preliminary research indicates that it may inhibit the growth of certain cancer cell lines by interfering with cellular signaling pathways. This aligns with the growing demand for novel natural product-derived therapeutics in oncology, as patients and healthcare providers seek treatments with fewer side effects.

In agricultural applications, Chaetoviridin A shows promise as a biopesticide. Its ability to target specific pests while being environmentally friendly makes it an attractive option for sustainable farming practices. As consumers increasingly demand organic produce and regulators tighten restrictions on synthetic pesticides, bio-based solutions like Chaetoviridin A are gaining traction in the agrochemical industry.

The production of Chaetoviridin A typically involves fermentation processes using fungal cultures. Recent advancements in metabolic engineering and bioprocessing technologies have improved yields and reduced production costs, making this compound more accessible for research and commercial applications. These developments are particularly relevant given the current focus on green chemistry and sustainable manufacturing practices.

From a market perspective, the demand for Chaetoviridin A is expected to grow steadily in coming years. The global market for bioactive fungal metabolites is projected to expand significantly, driven by increasing investment in natural product research and development. Pharmaceutical companies, agricultural firms, and research institutions are actively exploring the commercial potential of this compound.

Quality control and standardization remain important considerations for Chaetoviridin A applications. Analytical methods such as HPLC and mass spectrometry are commonly employed to ensure purity and consistency. These quality assurance measures are critical for meeting regulatory requirements and maintaining product efficacy across different applications.

Current research on Chaetoviridin A continues to uncover new potential uses. Recent studies have investigated its effects on neurodegenerative diseases and its potential as an immunomodulatory agent. These emerging applications align with global health trends and the increasing prevalence of age-related disorders in developed populations.

For researchers working with Chaetoviridin A, proper handling and storage are essential to maintain stability. The compound should be stored in airtight containers at recommended temperatures, protected from light and moisture. These precautions help preserve its biological activity and extend shelf life for experimental and commercial use.

The future of Chaetoviridin A research looks promising, with ongoing studies exploring structure-activity relationships and potential derivatives. The compound's unique chemical scaffold offers opportunities for medicinal chemistry modifications that could enhance its therapeutic properties. Such developments could lead to novel drugs addressing unmet medical needs in various therapeutic areas.

In conclusion, Chaetoviridin A (CAS No. 128252-98-2) represents an exciting area of natural product research with multiple potential applications. Its diverse biological activities, combined with increasing interest in sustainable and natural solutions across industries, position this compound as a valuable subject for continued investigation and development.

128252-98-2 (Chaetoviridin A) Related Products

Recommended suppliers
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Shenzhen Jianxing Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shenzhen Jianxing Pharmaceutical Technology Co., Ltd.
Hubei Cuiyuan Biotechnology Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hubei Cuiyuan Biotechnology Co.,Ltd
Xiamen PinR Bio-tech Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Xiamen PinR Bio-tech Co., Ltd.
Inner Mongolia Xinhong Biological Technology Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Inner Mongolia Xinhong Biological Technology Co., Ltd